Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy. (Q43814835)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584585%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584585%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584585%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Eduardo Molina-Holgado

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584585%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Paula Vieitez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584585%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Esther R Uceda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584585%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

María Eugenia Vera

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584585%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584585%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Renin-Angiotensin-Aldosterone System

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584585%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584585%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584585%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

96-102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584585%20AND%20SRC:MED&resulttype=core&format=json

Prevalence and trends of insulin resistance, impaired fasting glucose, and diabetes

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Recent advances in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Transforming growth factor beta contributes to progressive diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Renal hypertrophy in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Role of systolic blood pressureon the progression of kidney damage in an experimental model of type 2 diabetes mellitus, obesity, and hypertension (Zucker rats).

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

The podocyte: a potential therapeutic target in diabetic nephropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Immunosuppressive treatment protects against angiotensin II-induced renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Induction of vascular endothelial growth factor gene expression by proinflammatory cytokines in human pulp and gingival fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018

Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.018